|
|
- CAS号:
- 202350-68-3
- 英文名:
- PNU-159682
- 英文别名:
- PNU-159682;PNU-159682 95%;PNU-159682 >95%; 5-hydroxy-6-tert.-butyl-1,1-pentamethylene-3,3-dimethyl-indane;inhibit,non-Hodgkin’s lymphoma,PNU159682,ADCs Toxin,PNU-159682,acute myeloid leukemia,ADC Payload,EDV nanocell,AML,Inhibitor,ADC Cytotoxin,PNU 159682,Topoisomerase,NMS249,NHL;(8S,10S)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-{[(2S,4R,6S,7S,9R,10S)-10-methoxy-6-methyl-5,8,11-trioxa-1-azatricyclo[7.4.0.02,?]tridecan-4-yl]oxy}-5,7,8,9,10,12-hexahydrotetracene-5,12-dione;(8S,10S)-6,8,11-Trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-7,8,9,10-tetrahydrotetracene-5,12-dione;(8S,10S)-6,8,11-Trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-7,8,9,10-tetrahydrotetracene-5,12-dione;(8S,10S)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[(1S,3R,4aS,9S,9aR,10aS)-octahydro-9-methoxy-1-methyl-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy]-5,12-naphthacenedione;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[(1S,3R,4aS,9S,9aR,10aS)-octahydro-9-methoxy-1-methyl-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy]-, (8S,10S)-
- 中文名:
- PNU159682
- 中文别名:
- 蒽环类新霉素;化合物PNU-159682;拓扑异构酶抑制剂(PNU-159682);(8S,10S)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-10-(((1S,3R,4AS,9S,9AR,10AS)-9-甲氧基-1-甲基八氢-1H-吡喃并[4',3':4,5]恶唑并[2,3-C][1,4]恶嗪-3-基)氧基)-7,8,9,10-四氢并四苯-5,12-二酮;(8S,10S)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-10-(((1S,3R,4AS,9S,9AR,10AS)-9-甲氧基-1-甲基八氢-1H-吡喃并[4',3':4,5]恶唑并[2,3-C][1,4]恶嗪-3-基)氧基)-7,8,9,10-四氢并四苯-5,12-二酮;(8S,10S)-7,8,9,10-四氢-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-10-[[(1S,3R,4AS,9S,9AR,10AS)-八氢-9-甲氧基-1-甲基-1H-吡喃并[4',3':4,5]恶唑并[2,3-C][1,4]恶嗪-3-基]氧基] - 5,12-萘二酮
- CBNumber:
- CB12702958
- 分子式:
- C32H35NO13
- 分子量:
- 641.62
- MOL File:
- 202350-68-3.mol
|
|
|